The briefing
Long-term IDEA trial data suggest that skipping radiation in favorable breast cancer cases depends heavily on patients’ ability to tolerate and adhere to endocrine therapy. Oncologist Leah Katz, MD, MPH, discusses how adherence informs shared decision-making for selected patients.
Original headline
Radiation Omission in Favorable Breast Cancer Hinges on Endocrine Adherence